RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SICA S
Collezione AOU San Luigi di Orbassano

Items : 9

Efficacy and safety of nilotinib as frontline treatment in elderly (>?65 years) chronic myeloid leukemia patients outside clinical trials. in Annals of hematology / Ann Hematol. 2023 Jun;102(6):1375-1382. doi: 10.1007/s00277-023-05159-9. Epub 2023 Apr 20.

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Castagnetti F; Iurlo A; Sica S; Iovine M; Dragani M; Pregno P; Palmieri R; Albano F; Sorà F; Galimberti S; Esposito MR; Bocchia M; Sica A; Martino B; Tiribelli M; Annunziata M; Latagliata R; Gugliotta G; Luciano L; Rosti G; Breccia M;

The impact of education on patients' psycho-emotional status during allogeneic hematopoietic stem cell transplantation: a multicenter prospective study by thes Gruppo Italiano Trapianto di Midollo Osseo. in Journal of psychosocial oncology / J Psychosoc Oncol. 2023;41(6):687-703. doi: 10.1080/07347332.2023.2181722. Epub 2023 Feb 24.

2023
AOU San Luigi di Orbassano

Cioce M; Borrelli I; Cappucciati L; Giori M; Gobbi G; Lucifora R; Mabilia P; Marsullo M; Prendin C; Russo L; Zucca MS; Zega M; Sica S; Bacigalupo A; De Stefano V; Savoia V; Celli D; Garau P; Serra N; Botti S;

Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy. in Frontiers in oncology / Front Oncol. 2021 May 26;11:638689. doi: 10.3389/fonc.2021.638689. eCollection 2021.

2021
AOU San Luigi di Orbassano

Borghi L; Rosti G; Maggi A; Breccia M; Di Bona E; Iurlo A; La Barba G; Sportoletti P; Albano F; Galimberti S; Rivellini F; Cambrin GR; Capodanno I; Cuneo A; Bonifacio M; Sica S; Arcaini L; Capochiani E; Minotto C; Ciceri F; Crugnola M; Di Caprio L; Supekar S; Elena C; Baccarani M; Vegni E;

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study. in Blood / Blood. 2020 Feb 20;135(8):534-541. doi: 10.1182/blood.2019002969.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Pileri SA; Percesepe A; Laginestra MA; Mignone F; Vigneri P; Pane F; Errichiello S; Saglio G; Serra A; Stella S; Bocchia M; Calistri E; Annunziata M; Musolino C; Attolico I; Girasoli M; Coluzzi S; Capodanno I; Salvucci M; Sancetta R; Abruzzese E; Binotto G; D'Adda M; di Bona E; di Raimondo F; Stagno F; Russo Rossi AV; Albano F; Gugliotta G; et alii...

Chronic Myeloid Leukemia Patient's Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical Trial. in Frontiers in psychology / Front Psychol. 2019 Feb 20;10:329. doi: 10.3389/fpsyg.2019.00329. eCollection 2019.

2019
AOU San Luigi di Orbassano

Borghi L; Galimberti S; Baratè C; Bonifacio M; Capochiani E; Cuneo A; Falzetti F; Iurlo A; Lunghi F; Minotto C; Orlandi EM; Rege-Cambrin G; Sica S; Supekar S; Haenig J; Vegni E;

Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series. in Annals of hematology / Ann Hematol. 2018 Jan;97(1):95-100. doi: 10.1007/s00277-017-3144-1. Epub 2017 Oct 2.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Baccarani M; Specchia G; Cortelezzi A; Saglio G; Rosti G; Pane F; Bocchia M; Sica S; Breccia M; Luciano L; Martino B; Rege-Cambrin G; Stagno F; Castagnetti F; Gugliotta G; Tiribelli M; Gozzini A; Pungolino E; Bucelli C; Binotto G; Cattaneo D; Fava C; Orlandi EM; Sorà F; Ferrero D; Pregno P; Latagliata R; Annunziata M; Bonifacio M; et alii...

Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome. in British journal of haematology / Br J Haematol. 2018 Apr;181(2):267-270. doi: 10.1111/bjh.14553. Epub 2017 Feb 7.

2018
AOU San Luigi di Orbassano

Sora F; Iurlo A; Sica S; Latagliata R; Annunziata M; Galimberti S; Castagnetti F; Pregno P; Sgherza N; Celesti F; Bocchia M; Gozzini A; Fava C; Cattaneo D; Crugnola M; Montefusco E; Mauro E; Capodanno I; Breccia M; Sora F; Iurlo A; Sica S; Latagliata R; Annunziata M; Galimberti S; Castagnetti F; Pregno P; Sgherza N; Celesti F; et alii...

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome. in Oncotarget / Oncotarget. 2016 Nov 29;7(48):80083-80090. doi: 10.18632/oncotarget.11657.

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Orlandi EM; Galimberti S; Luciano L; Rege-Cambrin G; Sica S; Sorà F; Calistri E; Isidori A; Crugnola M; Giglio G; Celesti F; Spadea A; Mauro E; Avanzini P; Rossi AR; Cedrone M; Cortesi L; Scaffidi L; D'Addosio AM; Storti S; Gugliotta G; Montefusco E; Falzetti F; Russo S; Mansueto G; Binotto G; Cavazzini F; Annunziata M; Vigneri P; et alii...

Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival. in Leukemia research / Leuk Res. 2014 Oct;38(10):1173-6. doi: 10.1016/j.leukres.2014.06.020. Epub 2014 Jul 7.

2014
AOU San Luigi di Orbassano

Breccia M; Luciano L; Latagliata R; Castagnetti F; Ferrero D; Cavazzini F; Trawinska MM; Annunziata M; Stagno F; Tiribelli M; Binotto G; Crisà E; Musto P; Gozzini A; Cavalli L; Montefusco E; Iurlo A; Russo S; Cedrone M; Rossi AR; Pregno P; Endri M; Spadea A; Molica M; Giglio G; Celesti F; Sorà F; Storti S; D'Addosio A; et alii...